[Hypoxia as the main activator of angiogenesis and fatty tissue growth].
Kalinina NI., Efimenko AIu., Starostina EE., Parfenova EV., Tkachuk VA.
Narrative Review, published in Ross Fiziol Zh Im I M Sechenova (2009) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Ross Fiziol Zh Im I M Sechenova (2009)
- Country
- Russia (Federation)
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 19449784
Abstract (original English)
Poor content of oxygen indices gene expression for angiogenic growth factors both in adipocytes and in stromal cells of the fatty tissue. Stimulation of blood vessels by these factors leads to hyperplasia ofpregenitior cells and by their differentiation. This review mentions functional changes occurring in the fatty tissue cells under the effect of hypoxy.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.